GENEVA, July 1 -- LEAD DISCOVERY CENTER GMBH filed a patent application (EP2025/086829) for “INHIBITORY ANTIBODIES OF CYTOKINE INTERLEUKIN 11 DEPENDENT SIGNALING PATHWAYS”. With publication no. WO/2026/125705, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: A61P 35/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....